Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_DB08904
http://purl.obolibrary.org/obo/dinto_DB08904
|
|---|---|
| Preferred Name | certolizumab pegol |
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | certolizumab pegol
|
|---|---|
| label | certolizumab pegol
|
| DBSynonym | cdp870
|
| ATCCode | L04AB05
|
| Definition | Certolizumab pegol is a recombinant Fab antibody fragment against tumor necrosis factor alpha which is conjugated to an approximately 40kDa polyethylene glycol (PEG2MAL40K). Polyethylene glycol helps to delay the metabolism and elimination of the drugs. Chemically, the light chain is made up of 214 amino acid residues while the heavy chain is composed of 229 amino acid residues. The molecular mass of the Fab antibody fragment itself is 47.8 kDa. It is used for the treatment of rheumatoid arthritis and Crohn?s disease. FDA approved on April 22, 2008
|
| has pharmacological target | |
| type | |
| AHFScode | 56:92
|
| xref |
Drugs.com:http://www.drugs.com/ppa/certolizumab-pegol.html
Wikipedia:http://en.wikipedia.org/wiki/Certolizumab_pegol
RxList:http://www.rxlist.com/cimzia-drug.htm
National Drug Code Directory:50474-710-79
PharmGKB:PA165107055
|
| CASRN | 428863-50-7
|
| prefixIRI | obo2:dinto_DB08904
|
| related with | |
| may interact with | |
| DBBrand | cimzia
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |